Magnetic resonance imaging in patients with implantable cardioverter-defibrillators and pacemakers.

The number of patients who benefit from cardiovascular implantable electronic devices (CIEDs), which include pacemakers, biventricular pacing devices, and implantable cardioverter-defibrillators (ICDs), is increasing. This trend is likely to continue because of the growing proportion of the elderly

[1]  Robert Fair,et al.  Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. , 2004, Journal of the American College of Cardiology.

[2]  H. Schild,et al.  Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. , 2009, Journal of the American College of Cardiology.

[3]  Harold Litt,et al.  Strategy for Safe Performance of Extrathoracic Magnetic Resonance Imaging at 1.5 Tesla in the Presence of Cardiac Pacemakers in Non–Pacemaker-Dependent Patients: A Prospective Study With 115 Examinations , 2006, Circulation.

[4]  A. Siegbahn,et al.  Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease. , 2007, European heart journal.

[5]  H. Halperin,et al.  Clinical Utility and Safety of a Protocol for Noncardiac and Cardiac Magnetic Resonance Imaging of Patients With Permanent Pacemakers and Implantable-Cardioverter Defibrillators at 1.5 Tesla , 2006, Circulation.

[6]  O. Faris,et al.  Food and Drug Administration perspective: Magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. , 2006, Circulation.

[7]  Emanuel Kanal,et al.  Outcome of Magnetic Resonance Imaging (MRI) in Selected Patients with Implantable Cardioverter Defibrillators (ICDs) , 2005, Pacing and clinical electrophysiology : PACE.

[8]  Henry R. Halperin,et al.  Modern Pacemaker and Implantable Cardioverter/Defibrillator Systems Can Be Magnetic Resonance Imaging Safe: In Vitro and In Vivo Assessment of Safety and Function at 1.5 T , 2004, Circulation.

[9]  D. Bluemke,et al.  Safety of Magnetic Resonance Imaging in Patients With Cardiovascular Devices: An American Heart Association Scientific Statement From the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention , 2007, Circulation.

[10]  S. Priori,et al.  Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[11]  H. Schild,et al.  P Magnetic Resonance Imaging at 1 . 5T in Patients With Implantable Cardioverter-Defibrillators , 2022 .